Omni Star Financial Group, Inc. Gilead Sciences, Inc. Transaction History
Omni Star Financial Group, Inc.
- $126 Million
- Q3 2024
A detailed history of Omni Star Financial Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Omni Star Financial Group, Inc. holds 9,907 shares of GILD stock, worth $893,512. This represents 0.66% of its overall portfolio holdings.
Number of Shares
9,907
Previous 10,056
1.48%
Holding current value
$893,512
Previous $689,000
20.46%
% of portfolio
0.66%
Previous 0.66%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
1,923Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.9 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.57 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.43 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...